Global Fentanyl API Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Fentanyl is a synthetic opioid pain reliever, approved for treating severe pain, typically advanced cancer pain.1 It is 50 to 100 times more potent than morphine. It is prescribed in the form of transdermal patches or lozenges.

Market Analysis and Insights: Global Fentanyl API Market
In 2020, the global Fentanyl API market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Fentanyl API Scope and Market Size
The global Fentanyl API market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Fentanyl API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Purity 98%
Purity 99%

Segment by Application
Tablets
Lollipop
Spray
Injectant
Others

By Company
Mylan
AMRI
Cambrex
Rusan Pharma
Johnson Matthey
Northern Synthesis
Mallinckrodt
Arevipharma GmbH

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE